Trial Profile
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 27 Jul 2017 New trial record